Erasca Inc. Common Stock vs Kenvue Inc. Common Stock — how do they compare? Erasca Inc. Common Stock trades at $15.92 (market cap $5.40B), while Kenvue Inc. Common Stock trades at $17.71 (market cap $34.06B). The key difference: Kenvue Inc. Common Stock is far larger — about 6.3× Erasca Inc. Common Stock's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while Erasca Inc. Common Stock pays none. Which is the better fit depends on your goals.
| ERAS | KVUE | |
|---|---|---|
Market Cap | $5.40B | $34.06B |
Volume | 9,533,185 | 23,267,228 |
Sector | Health | Consumer Staples |
52-Week High | $22.47 | $19.83 |
52-Week Low | $2.20 | $14.11 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $5.18B | $41.56B |
Dividend Yield | — | 4.74% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Erasca is a biotechnology company developing precision medicines for cancer. Its programs target genetic drivers of tumor growth.
Read more on ERAS →Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →